Showing 1,181 - 1,200 results of 30,553 for search '(( 50 ((ng decrease) OR (((a decrease) OR (nn decrease)))) ) OR ( 2 step decrease ))', query time: 1.01s Refine Results
  1. 1181
  2. 1182
  3. 1183
  4. 1184
  5. 1185

    Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease by Watanabe N. (4118812)

    Published 2020
    “…Of the 27 patients with elevated hsTnI (≥5.0 pg/mL), the hsTnI level was normalized in 20 patients within a year. …”
  6. 1186
  7. 1187

    Diabetic kidney shows decreased klotho expression. by Jeong Suk Kang (7359572)

    Published 2021
    “…<p>(a) Representative images of the kidney from normal and diabetic biopsies showing the decreased klotho expression in diabetic podocytes by IHC. …”
  8. 1188

    Response of haemoglobin signals to a step up in demand. by Murad Banaji (269755)

    Published 2008
    “…<p>The response in <i>μ</i>M of ΔHbO2 (red), ΔHHb (green) and ΔHbt (black) to a step up in demand. …”
  9. 1189
  10. 1190
  11. 1191
  12. 1192
  13. 1193
  14. 1194
  15. 1195
  16. 1196
  17. 1197

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …”
  18. 1198

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …”
  19. 1199
  20. 1200

    Figure 3 from A Cost-Effective Two-Step Approach for Multi-Cancer Early Detection in High-Risk Populations by Shuaipeng Geng (20612220)

    Published 2025
    “…In the case–control cohort, the two-step MCED approach significantly improved specificity from 91.0% to 99.3%, whereas sensitivity decreased from 49.9% to 39.9%. …”